Best San Pod Productions Podcasts (2025)

1
GIRO D'ITALIA 2025 STAGE 2-4 and LA VUELTA FEMININA 2025 is Vollering's! 37:17

3h ago37:17

37:17

We kick off with La Vuelta Feminina as Katy talks us through the action where Demi Vollering reigns in Spain for 2025. Marlen Reusser takes second place across the seven days, and still on her comeback, Anna van der Breggen rounds off the podium. Then we're off to the Giro - Josh Tarling takes the Stage 2 Time Trial as Primoz Roglic wears pink from…

1
Executing A Product Pivot With Vir Bio's Mark Eisner, MD 39:45

3d ago39:45

39:45

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Bio, talks about the company's post-COVID pivot into infectious diseases (Hepatitis Delta and Hepatitis B) and oncology (solid tumors), how he reprioritized the company's development candida…

1
GIRO D'ITALIA 2025 STAGE 1 - Pedersen in pink, heartbreak for Landa and Red Bull KM, multi-screens and more! 34:29

4d ago34:29

34:29

Mads Pedersen pips Wout van Aert (where have we seen this before?!) to take the Maglia Rosa on Stage One of the Giro d'Italia. A perfect rac for Lidl Trek, not so for Mikel Landa - heartbreak as a crash with 5km to go means he pulls out. Sanny and Katy return to go through the start of the 2025 Giro ending in Albania's capital city, in a quickfire …

1
GIRO D'ITALIA 2025 PREVIEW - No Pog - Roglic vs Ayuso vs everyone else! 53:50

5d ago53:50

53:50

It's a Tadej Pogacar-free zone! Well, at least it will be when we talk Giro d'Italia. With last year's winner not returning, could there be a new rider lifting Trofeo Senza Fine and wearing La Maglia Rosa by the time we get to Rome in three weeks? Primoz Roglic get back in pink or Juan Ayuso young-gunning for a first Grand Tour win. Katy and Sanny …

1
Commercializing RNAi Therapies With Alnylam's Tolga Tanguler 55:54

10d ago55:54

55:54

We love to hear from our listeners. Send us a message. On today's episode, Tolga Tanguler, EVP and Chief Commercial Officer at Alnylam Pharmaceuticals, talks about commercializing RNAi therapies, how they fit into health insurance reimbursement systems, the company's use of value-based contracts, and building therapeutic franchise "skyscrapers." Ta…

1
Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie 55:45

17d ago55:45

55:45

We love to hear from our listeners. Send us a message. On today's episode I'm speaking with Brian Lortie, President and CEO of Uniquity Bio, about his "no jerk" policy and how his experience building teams at GSK, Endo Pharmaceuticals, and Onspira Therapeutics informs his leadership at Uniquity, a clinical-stage immunology startup backed by Blackst…

1
The Implications Of China's Growing Biotech Industry With Allan Shaw 46:08

24d ago46:08

46:08

We love to hear from our listeners. Send us a message. Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global innovation powerhouse. Increased deal activity with Chinese biopharmaceutical companies is injecting new risk into traditional development models in the We…

1
How To Be A CFO With Insmed's Sara Bonstein 44:20

1M ago44:20

44:20

We love to hear from our listeners. Send us a message. On today's episode we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provides useful insights on how to lead teams, especially when those teams have deeper subject matter expertise. Other topics discussed include when to make …

1
Tour of Flanders REVIEW - Pogacar and Kopecky Reign on the Ronde! 48:51

1M ago48:51

48:51

Was it ever in doubt? Maybe? Tadej Pogačar attacks exactly where you'd think he would be not before the rest of the peloton gave beating him a really good go. Sanny and Katy reconvene post-Ronde van Vlaanderen where there was a redemption, of sorts for Wout Van Aert, with Pedersen and van der Poel making the podium and kudos to Stuyven and Ganna in…

1
Deal And Investment Trends With Investment Banker David Sans 46:43

1M ago46:43

46:43

We love to hear from our listeners. Send us a message. Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engineering and molecular modeling, and a professional background that began in Big Pharma and shifted to investing over 15 years ago. Our conversation cov…

1
TOUR OF FLANDERS 2025 PREVIEW - Pogacar vs van der Poel, can Wout come back? Longo Borghini vs Kopecky vs Pieterse and AWKWARD sofas 42:33

1M ago42:33

42:33

Mathieu van der Poel is in form with wins at San Remo and E3 but Katy is backing Tadej Pogačar for victory in the biggest race in Belgium. After his and Visma Lease a Bike's nightmare at Dwars door Vlaanderen, Sanny and Katy discuss whether we'll ever see Wout van Aert back to his best. The women's race sees the formidable SD Worx Protime being the…

1
Roglic fantastic in Catalunya, MVDP reigns in the Classics, Wiebes 100 not out AND Matty Brennan a STAR IS BORN! 52:23

1M ago52:23

52:23

Mathieu van der Poel follows up Milan San Remo with a super win on the E3 Classic, There's consolation for Mads Pedersen who gets his Sunday victory at Gent-Wevelgem - more than just a consolation on the Classics Holy Week in Flanders. Lorena Wiebes makes it 100 not out with brilliant spring sprint victories in Belgium after her own San Remo succes…

1
Business of Biotech 2.0 with Ben Comer 34:44

1M ago34:44

34:44

We love to hear from our listeners. Send us a message. After nearly five years as host of the Business of Biotech podcast, Matt Pillar is handing the mic over to the voice of the Business of Biotech 2.0, veteran life sciences journalist Ben Comer. On this epsiode, Ben shares his nearly 20-year journey covering the pharmaceutical space, from Haymark…

1
Milan-San Remo REVIEW: Van der Poel vanquishes Top Ganna and Pogacar, Wiebes wins but how can we fix the women's race? Plus Tour de France UK 2027!! 51:43

2M ago51:43

51:43

Sanny and Katy talk through the men's and women's Milan-San Remo races with all you need to know going into them and out of them and Mathieu van der Poel comes out on top in a 'race for the ages'. The women’s race - well first off it’s back - and it’s Lorena Wiebes who again shows her sprinting might, edging out Marianne Vos when it mattered most. …

1
BoB@JPM: Nima Farzan, Latigo Biotherapeutics 43:32

2M ago43:32

43:32

We love to hear from our listeners. Send us a message. In this final installment of our episodes recorded and filmed on-site at the JP Morgan Healthcare Conference, Nima Farzan, CEO of Latigo Biotherapeutics, shares his company's mission to change the pain management paradigm by way of novel, non-opioid medications that target NAV 1.8 sodium channe…

1
BoB@JPM: Kasper Roet, Ph.D., QurAlis 43:46

2M ago43:46

43:46

We love to hear from our listeners. Send us a message. Dr. Kasper Roet's hands-on work at the Dutch Brain Bank informed his leadership at the biotech QurAlis, where three clinical programs targeting specific genetic mechanisms in ALS are now underway. On this episode of the Business of Biotech, Life Science Leader's Ben Comer joins to co-host a con…

1
STRADE BIANCHE REACTION! Vollering beats Van der Breggen! Pogacar, Pidcock and the Rainbow Curse! Plus 2026 changes and Roubaix Rumblings 48:11

2M ago48:11

48:11

What a brilliant couple of races into Siena! A battle only seen in Rocky films as Demi Vollering beats her mentor and old coach in Anna van der Breggen. In the men's race Tadej Pogacar gets a shoulder tap from history as he crashes in the rainbow bands but STILL wins in tuscany. We DO get the battle between Pogacar and Pidcock that Katy poo-pooed..…

1
BoB@JPM: Rick Modi, Affinia Therapeutics 52:20

2M ago52:20

52:20

We love to hear from our listeners. Send us a message. The latest in our series of Business of Biotech podcasts recorded in-person at JPM in San Francisco features an inspiring conversation with Affinia Therapeutics CEO Rick Modi. Modi shares on how his upbringing in Kenya shaped his adversity-embracing worldview, and how that worldview contributes…

1
Classics kick off! AND PREVIEW: PARIS-NICE, STRADE BIANCHE & TIRRENO ADRIATICO 1:06:36

2M ago1:06:36

1:06:36

Oof! Katy and Sanny return to review the opening Classics weekend. Om Loop had suprises in both the men's and women's pelotons! They dissect the rest of the big news and a look on races taking the wrong lines too AND THEN... it's a big preview - Paris-Nice, Strade Bianche and Tirreno Adriatico - A LOT to go at in a bumper episode! Presenters: Sanny…

1
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty 56:27

2M ago56:27

56:27

We love to hear from our listeners. Send us a message. On this episode of the Business of Biotech, recorded on-site at the 2025 JP Morgan Healthcare Conference, we explore a new approach to biotech financing with XOMA Royalty's Owen Hughes and Brad Sitko. The CEO and CIO, respectively, share an innovative royalty aggregation model that mitigates ri…

1
BoB@JPM: Tom Chalberg, Ph.D., Genascence 48:00

3M ago48:00

48:00

We love to hear from our listeners. Send us a message. Recorded in-person at the JP Morgan Healthcare Conference in San Franscisco, this episode finds Matt Pillar and Ben Comer exploring the evolution of gene therapy with Dr. Tom Chalberg, Founder, Chairman, & CEO at Genascence. We discuss ATMPS' transition from treating rare diseases to addressing…

1
BoB@JPM: Ran Zheng, Landmark Bio 37:00

3M ago37:00

37:00

We love to hear from our listeners. Send us a message. Ran Zhang was hire number one at Landmark Bio back in 2021. Today, she's CEO of the 70+ employee cell and gene therapy manufacturer. We caught up with her and Life Science Leader chief editor Ben Comer at the JP Morgan Healthcare Conference in San Francisco for a discussion on Landmark's role i…

1
Egan Bernal brilliance, oh man in Oman for Gaudu, Pogacar and Pidcock Paris-Roubaix? No way! 1:00:41

3M ago1:00:41

1:00:41

Loads and loads for Sanny and Katy to catch up on, in the women's and men's peloton. There's the Tadej Pogacar Paris-Roubaix rumours and confirmation from Tom Pidcock that, that ain't happening. Pidock wins his first race for Q36.5, whilst Adam Yates takes the Tour of Oman what exactly is Arabic for Peloton and, a better question , is everybody get…

1
BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics 45:07

3M ago45:07

45:07

We love to hear from our listeners. Send us a message. From the JP Morgan Healthcare Conference in San Francisco, Peter Anastasiou, CEO of Capsida Biotherapeutics, discusses his journey from big pharma to biotech and the challenges he's faces on the leading edge of first-gneration gene therapies. Anastasiou discusses the in-house manufacturing qual…

1
BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience 43:00

3M ago43:00

43:00

We love to hear from our listeners. Send us a message. From the JP Morgan Healthcare Conference in San Francisco, Dr. Stefan Scherer shares insight from 3T Bioscience's transition from clinical medicine to drug development, and his experiences in biotech leadership along the way. Dr. Scherer discusses the balance between promising advances in T-cel…

1
The Business Of CNS with Acumen's Jim Doherty, Ph.D. 47:51

4M ago47:51

47:51

We love to hear from our listeners. Send us a message. Life Science Leader's Ben Comer and Acumen Pharmaceuticals' Dr. Jim Doherty join the Business of Biotech to discuss Dr. Doherty's lifelong, singular focus on researching therapeis for CNS diseases. We cover the historical challenges associated with the development of new therapeutics for Alzhei…

1
Tour Down Under Women REVIEW - Ruegg reigns but will Dygert storm 2025? Caleb Ewan to INEOS and riders fighting kangaroos 37:23

4M ago37:23

37:23

Noemi Ruegg takes the title, thanks to a brilliant attack up Willunga Hill for stage 2. What else did we learn from the first World Tour race of the year for the women's peloton? Well, for one, Chloe Dygert is ready to go. Just like Ruegg, Daniek Hengeveld announces herself on the world stage, Sanny and Katy take you through all three stages of the…

1
High-Throughput Discovery With Bioptic's Andrey Dobry 1:13:36

4M ago1:13:36

1:13:36

We love to hear from our listeners. Send us a message. Andrey Doronichev, known to many simply as Dobry, is perhaps best known for taking YouTube mobile. You heard that right. If it weren't for him and the teams he led, YouTube might still be a desktop experience. He went on to lead product strategy at Google before launching the startup Optic in 2…

1
Tour Down Under PREVIEW, all go for Giro, Visma plans and banning celebrations?! 59:10

4M ago59:10

59:10

Happy 2025! Sanny and Katy are back together and looking to Australia as road racing returns! They review the Aussie national champs before looking ahead to both the women's and men's Tour down Under. We've got the latest from Visma's press day and on how teams' calendars are shaping up for 2025. There's a blow for Remco Evenepoel and Tom Pidcock's…

1
RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D. 1:06:32

4M ago1:06:32

1:06:32

We love to hear from our listeners. Send us a message. In close partnership woth Johns Hopkins and TriLink BioTechnologies, Jeff Coller, Ph.D. and Michelle Kim, Ph.D. have built a sandbox for RNA developers and aspirational RNA business builders to play in. On this week's episode of the Business of Biotech, we team up once again with Advancing RNA'…

1
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal) 54:04

4M ago54:04

54:04

We love to hear from our listeners. Send us a message. Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn from his time navigating medical affairs as CMO at Moderna during the COVID 19 pandemic to learn about his latest venture, an mRNA startup called Exsilio Therap…

1
Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D. 1:02:34

5M ago1:02:34

1:02:34

We love to hear from our listeners. Send us a message. Zandy Forbes, Ph.D. learned about business risk mitigation in the riskiest of business environments. She was a public markets healthcare investor on Wall Street for well more than a decade. Her hedge fund experience followed the Human Frontiers/Howard Hughes postdoctoral fellowship at the Skirb…

1
Biotech Story Time With Tal Zaks, M.D. (Part 1) 55:25

5M ago55:25

55:25

We love to hear from our listeners. Send us a message. Tal Zaks, M.D. was Chief Medical Officer at Moderna before, during, and immediately following the company's headline role during the COVID pandemic. If that doesn't pique your interest about the stories he can tell, this episode of the Business of Biotech surely will. Tal is now leading a new m…

1
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D. 52:50

5M ago52:50

52:50

We love to hear from our listeners. Send us a message. This past spring, Xaira Therapeutics launched with $1 billion in backing, a who's-who mashup of Silicon Valley and biopharma stars led by Marc Tessier-Lavigne in the C-suite, and a mission to develop AI-generated drugs. On this week's episode of the Business of Biotech, we're digging into the c…

1
Could Tom Pidcock be back to his best at Q36.5? Plus Pogacar's 2025 calendar! 42:46

5M ago42:46

42:46

It's been a long goodbye but our friend Daniel Benson was the man to break the news that Tom Pidcock has left INEOS for the second-tier Q36.5. How hs Pidcock's journey taken him to the Italian outfit and who exactly are they? Sanny and Katy are joined by Alicia Moyo to discuss Pidder's big move and why being the main man could mean we see him at hi…

1
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski 1:03:50

5M ago1:03:50

1:03:50

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jerry McLaughlin, CEO and President at Life Biosciences returns for a visit, and he brought a friend in John Maslowski, newly-appointed CEO at Forge Biologics. We revisit progress at Life Biosciences, followed by a deep look into the gears that…

1
Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D. 45:26

5M ago45:26

45:26

We love to hear from our listeners. Send us a message. Revolo Biotherapeutics President and CEO Woody Bryan, Ph.D. is pushing the boundaries of peptide therapeutic delivery. On this episode of the Business of Biotech, we dig into Dr. Bryan’s transition to the CEO chair at the company and how that coincided with an aggressive strategic decision to a…

1
Daniel Benson on Saint Piran's demise, Pidcock vs INEOS and the future of cycling media 1:00:15

6M ago1:00:15

1:00:15

Saint Piran announce they're folding and with that, the British men's professional road racing scene is down to just one team, INEOS Grenadiers. Just how bleak is it for cycling in the UK and are there any silver linings? Cycling writer and editor Daniel Benson gives his thoughts and we talk Tom Pidcock and INEOS, after Daniel broke lots of news on…

1
Biopolitics With Allan Shaw 49:54

6M ago49:54

49:54

We love to hear from our listeners. Send us a message. The notion that political influence has no place in biology appears poised for a test it hasn’t studied for. Trump administration nominations, from RFK, Jr. to HHS and Vivek Ramaswamy to the newly-proposed DOGE, are driving a storm of speculation over the implications for biotech and other life…

1
T-Cells For The Win With Adaptimmune's Adrian Rawcliffe 1:01:35

6M ago1:01:35

1:01:35

We love to hear from our listeners. Send us a message. In August of this year, the first TCR cell therapy to be approved for use in the U.S. was greenlighted by the FDA for patients with unresectable or metastatic synovial sarcoma who have previously received chemotherapy. It marked the first new treatment for those patients in more than a decade; …

1
Pidcock stays but all change at INEOS, goodbye Cavendish, Vollering flies to France and Blue Sky socials. 44:54

6M ago44:54

44:54

Pidcock stays, Cummings leaves, and a development team in the works - but they're German? It's all change at Britain's top team - we chat INEOS, Demi Vollering to FDJ Suez, the Tour de France routes for 2025, goodbye from Cavendish as Romain Bardet has his say on the pro peloton, will Blue Sky change cycling social media and much more on this editi…

1
Serving The Underserved With Gates MRI's Claire Wagner, M.D. 46:48

6M ago46:48

46:48

We love to hear from our listeners. Send us a message. On this episode of the Business of Biotech, Bill and Melinda Gates Medical Research Institute's (Gates MRI) Dr. Claire Wagner joins us to share insights into her work as head of Corporate Strategy and Market Access there. She shares the development of her North Star while working with the incom…

1
An Unanticipated Biotech Startup With OS Therapies' Paul Romness 49:12

6M ago49:12

49:12

We love to hear from our listeners. Send us a message. Becoming a biotech CEO wasn't on Paul Romness' bingo card. He'd forged his place in the biopharma industry as a foremost public and policy affairs expert. Thirteen years at J&J, more than 5 at Amgen, and half a dozen at Boehringer Ingelheim had earned him the right to coast into a consulting gi…

1
Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright 44:14

7M ago44:14

44:14

We love to hear from our listeners. Send us a message. It might just be coincidence, but it sure seems like Bill Enright has a knack for making big moves at inopportune times, then turning the expected outcome on its ear. For example, he signed on as CEO at Altimmune when the company was struggling mightily. Enright had a turnaround plan in hand, b…

1
Obesity Tx End-Around With Skye Bioscience's Punit Dhillon 1:02:41

7M ago1:02:41

1:02:41

We love to hear from our listeners. Send us a message. While the trend toward CB1 inhibition for obesity took a small hit with the release of Novo Nordisk's small molecule oral cannabinoid receptor (CB1) inverse agonist monlunabant last month, Skye Bioscience Chairman and CEO Punit Dhillon is shaking it off. He's confident that his company's antibo…

1
Pogacar & Kopecky dominate, Man V Horse and what's Pidcock's problem? 1:04:03

7M ago1:04:03

1:04:03

How many times will we say Tadej Pogacar is victorious on the road in 2024 - no more - the season is over as the Slovenian blows everyone away in Lombardia. Is road racing now the battle for second or even third when he’s racing? No Tom Pidcock present - has he thrown his toys out the pram one too many times at INEOS Grenadiers?! We have a big old …

1
Biotech C-Suite Construction With Allan Shaw 51:34

7M ago51:34

51:34

We love to hear from our listeners. Send us a message. Allan Shaw is back with us this week to dig into the complexities of strategic hiring in biotech. We cover strategies for the step-wise assembly of effective executive teams, the importance of aligning key hires with clinical and regulatory milestones, managing salaries in line with cash runway…

1
Gravel /not Gravel Worlds MVDP 'n' Vos Dutch Domination, Paris-Tours mud, Pogcar Reign-bow in Italy 54:21

7M ago54:21

54:21

It’s a Dutch domination at the Gravel Worlds as Marianne Vos and Mathieu van der Poel take gold. How much gravel do you need for a gravel race and should more events take in multi-story car parks? Looking at the finish photos from Paris-Tour - should that be called a gravel race instead?! There’s deja vu at Giro dell'emilia as Tadej Pogacar takes t…

1
The Peptide Promise With NervGen's Mike Kelly 59:19

7M ago59:19

59:19

We love to hear from our listeners. Send us a message. Mike Kelly faced a self-reckoning before he took the job as CEO at NervGen, a company developing peptide therapeutics targeted specifically at central nervous system repair. The veteran of life sciences business development knew the ropes of the biotech C-suite. He’d been a CEO twice before. He…

1
WORLDS REVIEW Pogacar Triple Crown, Queen Kopecky & Super Storey 1:00:23

8M ago1:00:23

1:00:23

Tadej Pogacar - wow. The third man ever to win the Giro, Tour de France and World title in the same year, as if you didn't already know! We look back at a mad 100km solo in the men's race. We reflect on Demi Vollering choosing violence that ultimately opened the door for Lotte Kopecky to defend her title and we bring you the para cycling headlines …

Podcasts Worth a Listen

San Pod Productions Podcasts

Podcasts Worth a Listen

Quick Reference Guide